Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.

Johanna SiminQing LiuXinchen WangKatja FallCecilia WilliamsSteven CallensLars EngstrandNele Brusselaers

Published in: Acta oncologica (Stockholm, Sweden) (2021)

Our findings suggest that E-MHT, but not EP-MHT use, might be associated with improved CRC survival, indicating a potential role of estrogens in sex hormone-related cancers. However, association of MHT use with grade of cancer remains unclear.

Keyphrases

papillary thyroid
free survival
polycystic ovary syndrome
squamous cell carcinoma
stem cells
estrogen receptor
childhood cancer
pregnancy outcomes
mesenchymal stem cells
young adults
bone marrow
cell therapy